Chronic Kidney Disease
RX Note
SEPTEMBER 10, 2023
Treating the underlying cause , such as diabetic kidney disease, viral infections, cardiac or hepatic disorders, administration of nephrotoxic drugs. Treatment with SGLT-2 inhibitors and glucagon-like peptide 1 (GLP-1) receptor agonists may reduce the risk of kidney disease progression in patients with type 2 diabetes. g/kg/day (0.6-0.8
Let's personalize your content